Coty 宣布完成收购金·卡戴珊个人美妆品牌 KKW Beauty 20％股份
华丽志2021-01-07 10:09
本周二，美国美妆巨头 Coty （科蒂）宣布完成以2亿美元收购美国网红 Kim Kardashian（金·卡戴珊）个人美妆品牌KKW Beauty 20％股份的交易。
这项交易最初是在去年6月份公布，Coty 计划为 KKW Beauty 扩展现有产品线，引入新的美容品类，包括在 2022 财政年度推出首个护肤系列。（详见《华丽志...查看全文
简介：Nabi Biopharmaceuticals
| 今开： | 昨收： |
| 最高： | 最低： |
| 涨停价： | 跌停价： |
| 总市值：305964000 |
华丽志2021-01-07 10:09
本周二，美国美妆巨头 Coty （科蒂）宣布完成以2亿美元收购美国网红 Kim Kardashian（金·卡戴珊）个人美妆品牌KKW Beauty 20％股份的交易。
这项交易最初是在去年6月份公布，Coty 计划为 KKW Beauty 扩展现有产品线，引入新的美容品类，包括在 2022 财政年度推出首个护肤系列。（详见《华丽志...查看全文
峰雾2011-09-11 01:24
关注$Nabi Biopharmaceuticals(NABI)$，当前价$1.75。查看全文
Eric0072011-09-06 17:48
关注$Nabi Biopharmaceuticals(NABI)$，当前价$1.82，目标价$2。查看全文
$Nabi Biopharmaceuticals(NABI)$ S-3 - Registration statement under Securities Act of 1933 Filed: 2018-12-20 AccNo: 0001513162-18-000319 Size: 1 MB 网页链接
$Nabi Biopharmaceuticals(NABI)$ 8-K - Current report Filed: 2018-12-18 AccNo: 0001513162-18-000314 Size: 28 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers 网页链接
$Nabi Biopharmaceuticals(NABI)$ 8-K - Current report Filed: 2018-11-20 AccNo: 0001513162-18-000297 Size: 19 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers 网页链接
$Nabi Biopharmaceuticals(NABI)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2018-11-13 AccNo: 0001513162-18-000292 Size: 8 MB 网页链接
$Nabi Biopharmaceuticals(NABI)$ 8-K - Current report Filed: 2018-11-09 AccNo: 0001513162-18-000284 Size: 184 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$Nabi Biopharmaceuticals(NABI)$ 10-Q - Quarterly report [Sections 13 or 15(d)] Filed: 2018-08-10 AccNo: 0001513162-18-000192 Size: 8 MB 网页链接
$Nabi Biopharmaceuticals(NABI)$ 8-K - Current report Filed: 2018-06-06 AccNo: 0001513162-18-000154 Size: 216 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain OfficersItem 9.01...
$Nabi Biopharmaceuticals(NABI)$ 8-K/A [Amend] - Current report Filed: 2018-04-27 AccNo: 0001513162-18-000109 Size: 441 KBItem 9.01: Financial Statements and Exhibits 网页链接
$Nabi Biopharmaceuticals(NABI)$ DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material Filed: 2018-02-26 AccNo: 0001193125-18-058552 Size: 273 KB 网页链接
$Nabi Biopharmaceuticals(NABI)$ DEF 14A - Other definitive proxy statements Filed: 2018-02-26 AccNo: 0001193125-18-058527 Size: 668 KB 网页链接